180 related articles for article (PubMed ID: 22742733)
1. Over-expression of cofilin-1 and phosphoglycerate kinase 1 in astrocytomas involved in pathogenesis of radioresistance.
Yan H; Yang K; Xiao H; Zou YJ; Zhang WB; Liu HY
CNS Neurosci Ther; 2012 Sep; 18(9):729-36. PubMed ID: 22742733
[TBL] [Abstract][Full Text] [Related]
2. Molecular interactions of ErbB1 (EGFR) and integrin-β1 in astrocytoma frozen sections predict clinical outcome and correlate with Akt-mediated in vitro radioresistance.
Petrás M; Lajtos T; Friedländer E; Klekner A; Pintye E; Feuerstein BG; Szöllosi J; Vereb G
Neuro Oncol; 2013 Aug; 15(8):1027-40. PubMed ID: 23595626
[TBL] [Abstract][Full Text] [Related]
3. Phosphoglycerate kinase 1 promotes radioresistance in U251 human glioma cells.
Ding H; Cheng YJ; Yan H; Zhang R; Zhao JB; Qian CF; Zhang WB; Xiao H; Liu HY
Oncol Rep; 2014 Feb; 31(2):894-900. PubMed ID: 24284928
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of phosphoglycerate kinase 1 by shRNA sensitizes U251 xenografts to radiotherapy.
Cheng YJ; Ding H; Du HQ; Yan H; Zhao JB; Zhang WB; Zou YJ; Liu HY; Xiao H
Oncol Rep; 2014 Oct; 32(4):1513-20. PubMed ID: 25175369
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of p-Mnk1, p-eIF4E and p-p70S6K proteins are associated with tumor recurrence and poor prognosis in astrocytomas.
Fan W; Wang W; Mao X; Chu S; Feng J; Xiao D; Zhou J; Fan S
J Neurooncol; 2017 Feb; 131(3):485-493. PubMed ID: 27900644
[TBL] [Abstract][Full Text] [Related]
6. Cofilin-1 and phosphoglycerate kinase 1 as promising indicators for glioma radiosensibility and prognosis.
Sun W; Yan H; Qian C; Wang C; Zhao M; Liu Y; Zhong Y; Liu H; Xiao H
Oncotarget; 2017 Aug; 8(33):55073-55083. PubMed ID: 28903403
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy with or without surgery in the management of low-grade brain astrocytomas. A retrospective study of 120 patients.
Touboul E; Schlienger M; Buffat L; Balosso J; Minne JF; Schwartz LH; Pene F; Masri-Zada T; Lot G; Devaux B
Bull Cancer Radiother; 1995; 82(4):388-95. PubMed ID: 8554892
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.
Zhuang Z; Qi M; Li J; Okamoto H; Xu DS; Iyer RR; Lu J; Yang C; Weil RJ; Vortmeyer A; Lonser RR
J Neurosurg; 2011 Oct; 115(4):789-95. PubMed ID: 21682567
[TBL] [Abstract][Full Text] [Related]
10. Nitroproteins in Human Astrocytomas Discovered by Gel Electrophoresis and Tandem Mass Spectrometry.
Peng F; Li J; Guo T; Yang H; Li M; Sang S; Li X; Desiderio DM; Zhan X
J Am Soc Mass Spectrom; 2015 Dec; 26(12):2062-76. PubMed ID: 26450359
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.
Nakamura M; Konishi N; Tsunoda S; Hiasa Y; Tsuzuki T; Inui T; Sakaki T
Cancer; 1997 Jul; 80(2):242-9. PubMed ID: 9217037
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy.
Mastronardi L; Puzzilli F; Guiducci A
Neurosurgery; 1998 Dec; 43(6):1496. PubMed ID: 9848870
[No Abstract] [Full Text] [Related]
13. Conformal proton radiation therapy for pediatric low-grade astrocytomas.
Hug EB; Muenter MW; Archambeau JO; DeVries A; Liwnicz B; Loredo LN; Grove RI; Slater JD
Strahlenther Onkol; 2002 Jan; 178(1):10-7. PubMed ID: 11977386
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma.
Matusan-Ilijas K; Behrem S; Jonjic N; Zarkovic K; Lucin K
Pathol Oncol Res; 2008 Sep; 14(3):293-8. PubMed ID: 18493866
[TBL] [Abstract][Full Text] [Related]
15. Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers.
Polisetty RV; Gautam P; Gupta MK; Sharma R; Gowda H; Renu D; Shivakumar BM; Lakshmikantha A; Mariswamappa K; Ankathi P; Purohit AK; Uppin MS; Sundaram C; Sirdeshmukh R
Sci Rep; 2016 Jun; 6():26882. PubMed ID: 27246909
[TBL] [Abstract][Full Text] [Related]
16. [IDH1 mutation and MGMT expression in astrocytoma and the relationship with prognosis after radiotherapy].
Jiang M; Dong X; Li J; Li J; Qi J
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):668-72. PubMed ID: 25567592
[TBL] [Abstract][Full Text] [Related]
17. The expression of moesin in astrocytoma: correlation with pathologic grade and poor clinical outcome.
Wu M; Liu DY; Yuan XR; Liu Q; Jiang XJ; Yuan D; Huang J; Li XJ; Yang ZQ
Med Oncol; 2013 Mar; 30(1):372. PubMed ID: 23315217
[TBL] [Abstract][Full Text] [Related]
18. Management of pilocytic astrocytoma.
Kayama T; Tominaga T; Yoshimoto T
Neurosurg Rev; 1996; 19(4):217-20. PubMed ID: 9007882
[TBL] [Abstract][Full Text] [Related]
19. High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas.
Araki K; Nozaki K; Ueba T; Tatsuka M; Hashimoto N
J Neurooncol; 2004; 67(1-2):53-64. PubMed ID: 15072448
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for pilocytic astrocytomas of childhood.
Mansur DB; Rubin JB; Kidd EA; King AA; Hollander AS; Smyth MD; Limbrick DD; Park TS; Leonard JR
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):829-34. PubMed ID: 20421157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
